Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Gen Trak, Inc. — Predicate Candidate Screening
5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
235 daysmedian FDA review time
235 days90th percentile
5clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K922084 | MONOMCLONAL ANTIBODY IGG1 ISOTYPE CONT. FLOW CYTOM | Gen Trak, Inc. | 1992-07-28 | 85 | 0 |
| K922085 | MONOCLONAL ANTIBODY IGG2A ISOTYPE CONT. FLOW CYTOM | Gen Trak, Inc. | 1992-07-28 | 85 | 0 |
| K914847 | CD8 MONOCLONAL ANTIBODIES | Gen Trak, Inc. | 1992-06-19 | 235 | 0 |
| K914848 | CD4 MONOCLONAL ANTIBODIES | Gen Trak, Inc. | 1992-06-19 | 235 | 0 |
| K914846 | CD2 MONOCLONAL ANTIBODIES | Gen Trak, Inc. | 1992-06-19 | 235 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda